Drug Schedules under the Drugs & Cosmetics Act

Drug Schedules under the Drugs & Cosmetics Act

1. Definition, statutory architecture & scope

• The Drugs Act, 1940 was passed to control the manufacture, sale and distribution of allopathic drugs in India; it was later amended to also cover Ayurvedic, Unani, Siddha and Homoeopathic drugs (Padmaja 7e Ch.5, p.75).
• A 1962 amendment added cosmetics, and the title became the Drugs and Cosmetics Act — under which clear rules were framed for the import, manufacture, sale, labelling and packing of drugs (Padmaja 7e Ch.5, p.75).
• Two-tier legal structure. The Drugs and Cosmetics Act, 1940 is the parent legislation passed by Parliament; the Drugs and Cosmetics Rules, 1945 are delegated (subordinate) legislation framed under it, amendable by the Central Government by gazette notification (G.S.R.) without re-legislating [D&C Rules 1945].
  • This is why virtually every amendment cited in the Rules appears as a footnote of the form "Ins. by G.S.R. 588(E), dt. 30-8-2013" or "Subs. by G.S.R. 462(E), dt. 22-6-1982" — the schedule content moves by executive notification, not by an Act of Parliament [D&C Rules 1945].
  • Exam consequence: almost all schedules (A–Y) are appended to the Rules, not to the Act. Only two schedules belong to the Act itself [D&C Rules 1945].
• A "Schedule" is an annexure to the Rules that groups drugs (or forms, fees, standards, premises requirements, exempted categories) sharing a common regulatory treatment, and prescribes the labelling, prescription, sale, storage, record-keeping, manufacturing or testing obligations attaching to that group [D&C Rules 1945].
• Every schedule is operative only through a Rule. A schedule never stands alone: its heading always carries a "(See Rule N)" cross-reference, and the substantive obligation lives in that Rule. Learning the schedule–rule pairings is the single highest-yield way to master this topic [D&C Rules 1945].
  • Schedule G, H, H1, X → Rules 65 and 97 (conditions of sale + labelling).
  • Schedule C, C(1) → Rules 23, 61, 76 and Part X (licensing/import/manufacture of biologicals).
  • Schedule P → Rule 96 (manner of labelling — date of manufacture/expiry).
  • Schedule P1 → Rules 105 and 109 (pack sizes).
  • Schedule J → Rule 106 (prohibited disease claims).
  • Schedule K → Rule 123 (exemptions from Chapter IV).
  • Schedule M → Rules 71, 74, 76 and 78 (GMP, premises, plant and equipment).
  • Schedule N → Rule 64(1) (minimum pharmacy equipment).
  • Schedule Y → Rules 122A, 122B, 122D, 122DA, 122DAA and 122E (import/manufacture of new drugs, clinical trials).
  • Schedule X additionally → Rules 23, 61, 75, 97 and 105A (licensing, storage, labelling, pack size).
• Schedules to the Act itself (two only): the First Schedule (the authoritative Ayurveda/Siddha/Unani formulary reference books, which define the legal standard for ASU drugs) and the Second Schedule (standards of quality for imported, manufactured or stocked drugs) [D&C Rules 1945].
• The Rules carry an alphabetical run A → Y, with sub-schedules (B(1), C(1), D(I)/D(II)/D(III), E(1), F(I)/F(II)/F(III)/FF, M-I/M-II/M-III, P1, U(I)). There is no Schedule W in the current Rules — it was omitted, and Schedule I was likewise omitted by G.S.R. 462(E), dt. 22-6-1982 [D&C Rules 1945].
  • ⚠ A frequently-repeated exam claim that "the Rules carry schedules A to Y continuously" is only loosely true: I and W are absent, and E exists only as E(1) [D&C Rules 1945].
• Topic scope note: "drug schedules" here means the Indian D&C Act/Rules schedule system — not the "scheduling" of controlled substances under the US Controlled Substances Act, and not the NDPS Act, 1985 drug lists. The NDPS Act is a separate statute; the D&C Rules only cross-refer to it (for the NRx labelling requirement under Rule 97(1)(c)) [D&C Rules 1945, Rule 97].
• Regulators. The Central Drugs Standard Control Organisation (CDSCO), headed by the Drugs Controller General of India (DCGI), is the central licensing authority — new-drug approval, clinical-trial permission, import registration, Schedule C/C(1) and Schedule X oversight, blood-bank licensing. State Drug Control Authorities / State Licensing Authorities license manufacture and retail/wholesale sale, and appoint the Drugs Inspectors who enforce the register and storage obligations [CDSCO][D&C Rules 1945, Rule 21].
• Enforcement architecture. A retail/wholesale licence (Forms 20, 20-A, 20-B, 20-F, 20-G, 21, 21-B) is granted subject to the general conditions of Rule 65; breach of any Rule-65 condition is a ground for suspension or cancellation of the licence under Rule 66, after a show-cause opportunity [D&C Rules 1945, Rules 65 & 66].
• Every licensee must produce all registers and records for inspection by a Drugs Inspector on demand, and must maintain an Inspection Book in Form 35 for the Inspector to record his observations and the defects noticed [D&C Rules 1945, Rule 65(6) & 65(16)].
• Default record-retention period: unless a Rule says otherwise, all registers and records must be preserved for not less than two years from the date of the last entry — this is the baseline against which the special Schedule H1 (3 years) and Schedule X (2 years, plus a bound register) periods should be contrasted [D&C Rules 1945, Rule 65(7)].